Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

hu1124

Known as: Hu 1124 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2005
Review
2005
OBJECTIVE: To review the pharmacology, efficacy, and safety of efalizumab for the treatment of moderate to severe plaque… Expand
  • table 1
  • table 3
  • table 4
Highly Cited
2004
Highly Cited
2004
The pharmacokinetics of hu1124, a human anti-CD11a antibody, were investigated in human subjects with psoriasis. CD11a is a… Expand
  • figure 1
  • figure 2
  • figure 3
  • table I
  • table II
Highly Cited
2001
Highly Cited
2001
BACKGROUND Anti-CD11a (hu1124) is a humanized monoclonal antibody directed against the CD11a subunit of LFA-1. This study… Expand
Review
2001
Review
2001
  • F. Vincenti
  • Transplantation proceedings
  • 2001
  • Corpus ID: 1007713
BIOLOGIC agents have been used in transplantation in the prophylaxis of rejection, in the induction phase of therapy, and in the… Expand
Highly Cited
2000
Highly Cited
2000
BACKGROUND CD11a/CD18 comprise subunits of leukocyte function associated antigen (LFA-1), a T-cell surface molecule important in… Expand
2000
2000
  • H. Granlund
  • IDrugs : the investigational drugs journal
  • 2000
  • Corpus ID: 10234921
Genentech and XOMA are collaborating in the development of a humanized monoclonal antibody, hu1124 (anti-CD11a), which has the… Expand
2000
2000
  • 2000
  • Corpus ID: 195131707